Home › Targets › transthyretin
transthyretin (1 companies · 8 programs)
Companies with an active program directed at transthyretin.
- WAINUA — Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Approved
- WAINUA — Transthyretin-Mediated Amyloid Cardiomyopathy Phase 3
- TEGSEDI — Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Approved
- WAINUA — Transthyretin Amyloid Cardiomyopathy Phase 3
- WAINUA — Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy Approved
- TEGSEDI — Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy Approved
- WAINUA — Transthyretin Amyloidosis Cardiomyopathy Phase 3
- WAINUA — Transthyretin Amyloidosis Approved
